FdaApplication
ANDA 210197
Identifiers
- fda_app_no: ANDA210197
Properties
| Property | Value |
|---|---|
| applicant_name | REGCON HOLDINGS LLC |
| application_type | ANDA |
| approval_date | 2024-01-12 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 250MG BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS |
| CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 2GM BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS |
| CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS |
| CEFTRIAXONE | CEFTRIAXONE SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS |
4 products